| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/02/2003 | EP1267875A1 Sigma receptor ligands and their medical uses |
| 01/02/2003 | EP1267873A2 A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer |
| 01/02/2003 | EP1267872A2 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
| 01/02/2003 | EP1267871A2 Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives |
| 01/02/2003 | EP1267866A2 The treatment of respiratory diseases |
| 01/02/2003 | EP1267860A1 Butylnitrone containing compositions for inhibition of cancer development |
| 01/02/2003 | EP1267851A2 Method and compositions for preventing hormone induced adverse effects |
| 01/02/2003 | EP1267848A1 Dosing regimen comprising a farnesyl protein transferase inhibitor for the treatment of cancer |
| 01/02/2003 | EP1267843A1 System for transporting active substances in a biological system |
| 01/02/2003 | EP1267839A2 Microspheres for active embolization |
| 01/02/2003 | EP1267837A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 01/02/2003 | EP1267835A1 D and l etherlipid stereoisomers and liposomes |
| 01/02/2003 | EP1115716B1 2-phenylpyran-4-one derivatives |
| 01/02/2003 | EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 01/02/2003 | EP1073654A4 2,3-olefinic epothilone derivatives |
| 01/02/2003 | EP1073648A4 12,13-modified epothilone derivatives |
| 01/02/2003 | EP1073647A4 12,13-cyclopropane epothilone derivatives |
| 01/02/2003 | EP0989989B1 13-dihydro-3'aziridino anthracyclines |
| 01/02/2003 | EP0980383B1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 01/02/2003 | EP0980382B1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 01/02/2003 | EP0979284B1 Reagents for vaccination which generate a cd8 t cell immune response |
| 01/02/2003 | EP0806960B1 Extracts of shark cartilage, process of production and uses thereof |
| 01/02/2003 | EP0771216B9 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/02/2003 | EP0745131B1 Targeting gene therapy |
| 01/02/2003 | CA2391753A1 Combination chemotherapy |
| 01/01/2003 | CN1388808A Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same |
| 01/01/2003 | CN1388760A Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
| 01/01/2003 | CN1388248A Adenovirus proliferated specifically inside tumor cell to express interferon in high efficiency and its construction method |
| 01/01/2003 | CN1388135A Monoclonal antibody capable of priming cancer cell death |
| 01/01/2003 | CN1388126A 吡咯并三嗪和嘧啶化合物 Pyrrolo-triazine and pyrimidine compounds |
| 01/01/2003 | CN1387873A Medicine for treating tumor in digestive tract and its prepn |
| 01/01/2003 | CN1387862A Prepn of leukemia treating medicine with internal organs of scallop |
| 01/01/2003 | CN1387861A Yunnan Heiyao and its application in treating tumors |
| 01/01/2003 | CN1387855A Licorice polysaccharide powder injection |
| 01/01/2003 | CN1387851A Nasal cavity administrated prepn for treating cerebral tumor |
| 01/01/2003 | CN1097579C Ortho-substituted benzoylguanidines, process for their preparation, use and medicine containing them |
| 01/01/2003 | CN1097460C Amino sugar and related sugar derivatives of cytotoxic of indolopyrro locarbazoles |
| 01/01/2003 | CN1097458C Stable oil-in-water emulsions containing taxine (taxol) and its producing process |
| 12/31/2002 | USRE37952 Grb3-3 cDNA and polypeptides |
| 12/31/2002 | US6500937 Plasmid or vector; sequence encodes mammastatin; useful in the diagnosis and treatment of breast cancer |
| 12/31/2002 | US6500936 Glycerol culture of actinomyces |
| 12/31/2002 | US6500924 Package for using antagonists of the vitronectin receptor alpha-v beta3 comprising a metalloproteinase polypeptide of given amino acid sequence; treating arthritis, rheumatoid arthritis, retinopathy and tumors |
| 12/31/2002 | US6500919 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 12/31/2002 | US6500868 Method for preventing and treating peripheral neuropathy by administering selegiline |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500860 For inhibiting motility of sperm; for inducing destruction of testicular germ cells |
| 12/31/2002 | US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators |
| 12/31/2002 | US6500846 2-(4-chlorophenyl)-7-methoxychromen-4-one, as cyclin-dependent kinase inhibitors, used as anticarcinogenic agents or for prophylaxis of neurodegenerative disease |
| 12/31/2002 | US6500841 Inhibitors of farnesyl-protein transferase |
| 12/31/2002 | US6500829 Mixtures of stereoisomers used as anticarcinogenic agents or for the treatment of vitamin deficiency |
| 12/31/2002 | US6500818 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/31/2002 | US6500815 Bone disorders |
| 12/31/2002 | US6500814 Hormonal contraceptive |
| 12/31/2002 | US6500811 Prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved; these include degenerative joint disorders such as osteoarthroses and disorders of connective tissue |
| 12/31/2002 | US6500805 Fructan containing composition for the prevention and treatment of colon cancer and method for the prevention and treatment of same |
| 12/31/2002 | US6500654 Cardiac-related ankyrin-repeat protein kinase |
| 12/31/2002 | US6500642 Mammalian cdna which encodes a mammalian mapop-3. it also provides for the use of the cdna, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of breast |
| 12/31/2002 | US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 12/31/2002 | US6500610 Administering compounds that exhibit phosphodiesterase and cyclooxygenase inhibitory activity and apoptosis induction but prefereably not prostaglandin inhibitory activity on cultured tumor cells |
| 12/31/2002 | US6500472 For enriching foods or beverages, anemia treatment |
| 12/31/2002 | US6500467 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500431 Inhibitors of angiogenesis and tumor growth |
| 12/31/2002 | US6500424 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 12/31/2002 | US6500423 Probiotic composition comprising viable escherichia coli strain bu-230-98 atcc deposit no. 20226 (dsm 12799) and a formulation for maintaining viability of said escherichia coli strain |
| 12/31/2002 | CA2097732C Composition comprising r-alpha-lipoic acid and vitamin e for treating diabetes mellitus |
| 12/31/2002 | CA2096532C New human recombinant gamma-interferon |
| 12/31/2002 | CA2094121C 5-iodo-6-amino-1,2-benzopyrones and their analogs useful as cytostatic and antiviral agents |
| 12/31/2002 | CA2044812C Radiopharmaceutical formulations, their method of administration and process of preparation |
| 12/30/2002 | WO2002002582A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same |
| 12/30/2002 | CA2414605A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same |
| 12/29/2002 | CA2392383A1 A complex comprising ocif and polysaccharide |
| 12/27/2002 | WO2002103362A2 Cancer associated protein |
| 12/27/2002 | WO2002103055A1 METHOD OF DETERMINING A CHEMOTHERAPEUTIC REGIMEN BASED ON GLUTATHIONE-S-TRANSFERASE Pi EXPRESSION |
| 12/27/2002 | WO2002103042A2 Method and nucleic acids for the differentiation of prostate tumors |
| 12/27/2002 | WO2002103031A2 Methods for detecting and treating the early onset of aging-related conditions |
| 12/27/2002 | WO2002103014A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 12/27/2002 | WO2002103000A2 Methods for modulating gap junctions |
| 12/27/2002 | WO2002102997A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/27/2002 | WO2002102990A2 Fibroblast growth factor and nucleic acid encoding same |
| 12/27/2002 | WO2002102984A2 Hdac9 polypeptides and polynucleotides and uses thereof |
| 12/27/2002 | WO2002102978A2 Human growth hormone antagonists |
| 12/27/2002 | WO2002102976A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 12/27/2002 | WO2002102973A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102972A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102854A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102846A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 12/27/2002 | WO2002102828A2 Chimeric flavivirus vectors |
| 12/27/2002 | WO2002102825A2 Fluorescently labelled locked nucleic acids |
| 12/27/2002 | WO2002102817A1 Anti-tumour anthracycline glycoside 14-sulfonic acid derivatives |
| 12/27/2002 | WO2002102805A1 NEW USE Of CYCLOLIGNANS AND NEW CYCLOLIGNANS |
| 12/27/2002 | WO2002102804A1 New use of specific cyclolignans |
| 12/27/2002 | WO2002102800A1 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors |
| 12/27/2002 | WO2002102787A2 Novel sulfonic acid derivatives |
| 12/27/2002 | WO2002102784A2 2-adamantyl-4,6-diamino-1,2-dihydro-1-aryl-1,3,5-triazine derivatives as cell prolifiration inhibitors |
| 12/27/2002 | WO2002102783A1 Tyrosine kinase inhibitors |
| 12/27/2002 | WO2002102771A1 Tryptase inhibitors |
| 12/27/2002 | WO2002102768A2 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 12/27/2002 | WO2002102407A1 Therapeutical vaccination |
| 12/27/2002 | WO2002102403A1 Mucosal repair by tff dimer peptides |
| 12/27/2002 | WO2002102394A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |